mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
0.024 |
0.7 |
mRNA |
Z-LLNle-CHO |
GDSC1000 |
pan-cancer |
AAC |
0.024 |
0.7 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
A-443654 |
GDSC1000 |
pan-cancer |
AAC |
0.025 |
0.7 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.7 |
mRNA |
17-AAG |
FIMM |
pan-cancer |
AAC |
-0.085 |
0.7 |